| 000 | 01537 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516031144.0 | ||
| 264 | 0 | _c20110630 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1423-0232 | ||
| 024 | 7 |
_a10.1159/000322498 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKim, Seung Tae | |
| 245 | 0 | 0 |
_aSelection of a patient subgroup with advanced esophageal squamous carcinoma who could benefit from second-line chemotherapy. _h[electronic resource] |
| 260 |
_bOncology _c2010 |
||
| 300 |
_a363-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPark, Kyong Hwa | |
| 700 | 1 | _aOh, Sang Cheul | |
| 700 | 1 | _aSeo, Jae Hong | |
| 700 | 1 | _aShin, Sang Won | |
| 700 | 1 | _aKim, Jun Suk | |
| 700 | 1 | _aKim, Yeul Hong | |
| 773 | 0 |
_tOncology _gvol. 79 _gno. 5-6 _gp. 363-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000322498 _zAvailable from publisher's website |
| 999 |
_c20700353 _d20700353 |
||